FLOMENBERG NEAL (Chief Scientific Officer) sold 1.2% of their position (972.00 shares) of TEVOGEN BIO HOLDINGS INC. on the open market
Open‑market sale worth $6.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 3/17/2026ACC: 0001123292-26-000465
Officer· Chief Scientific Officer
Since Feb 2024
-972.00
Net shares
Net seller
$6.6K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
972.00 disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−19.00
Price / share
$7.75
Trade value
$147.25
% of position
0.0%
3/10/2026
77.91K→77.89K
Common Stock
Direct
Shares
−452.00
Price / share
$7.26
Trade value
$3.28K
% of position
0.6%
3/11/2026
77.89K→77.44K
Common Stock
Direct
Shares
−501.00
Price / share
$6.40
Trade value
$3.21K
% of position
0.6%
3/13/2026
77.44K→76.94K
Total
Net shares
−972.00
Net value
-$6.64K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/10/2026 | S · Sale | −19.00 | $7.75 | $147.25 | 0.0% | 77.91K | 77.89K |
| Common Stock Direct | 3/11/2026 | S · Sale | −452.00 | $7.26 | $3.28K | 0.6% | 77.89K | 77.44K |
| Common Stock Direct | 3/13/2026 | S · Sale | −501.00 | $6.40 | $3.21K | 0.6% | 77.44K | 76.94K |
| Total | −972.00 | -$6.64K | ||||||
Derivative Transactions0
No derivative transactions reported